tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PMVP Stock Latest News

PMV Pharmaceuticals initiated with a Buy at Jefferies
The FlyPMV Pharmaceuticals initiated with a Buy at Jefferies
8d ago
PMVP
PMV Pharmaceuticals announces first patient dosed in Phase 2 PYNNACLE trial
PremiumThe Fly
PMV Pharmaceuticals announces first patient dosed in Phase 2 PYNNACLE trial
24d ago
PMVP
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
PremiumPress Releases
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
24d ago
PMVP
PMV Pharmaceuticals reports promising efficacy of rezatapopt in OC study
PremiumThe Fly
PMV Pharmaceuticals reports promising efficacy of rezatapopt in OC study
1M ago
PMVP
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
PremiumPress Releases
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
1M ago
PMVP
PMV Pharmaceuticals reportsFY23 EPS ($1.44), consensus ($1.52)
PremiumThe FlyPMV Pharmaceuticals reportsFY23 EPS ($1.44), consensus ($1.52)
2M ago
PMVP
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
PremiumPress Releases
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
2M ago
PMVP
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
PremiumPress Releases
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
2M ago
PMVP
PMV Pharmaceuticals annouces strategic 30% workforce reduction
PremiumThe Fly
PMV Pharmaceuticals annouces strategic 30% workforce reduction
3M ago
PMVP
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
PremiumPress Releases
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
3M ago
PMVP
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
PremiumPress Releases
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
4M ago
PMVP
PMV Pharmaceuticals names Michael Carulli as CFO, succeeding Winston Kung
PremiumThe Fly
PMV Pharmaceuticals names Michael Carulli as CFO, succeeding Winston Kung
4M ago
PMVP
Gracell downgrade, Fusion upgrade: Wall Street’s top analyst calls
PremiumThe FlyGracell downgrade, Fusion upgrade: Wall Street’s top analyst calls
4M ago
AZN
LLY
Ladenburg starts ‘undervalued and oversold’ PMV with Buy
PremiumThe Fly
Ladenburg starts ‘undervalued and oversold’ PMV with Buy
4M ago
PMVP
PMV Pharmaceuticals initiated with a Buy at Ladenburg
PremiumThe Fly
PMV Pharmaceuticals initiated with a Buy at Ladenburg
4M ago
PMVP
PMV Pharmaceuticals reports Q3 EPS (34c), consensus (45c)
PremiumThe Fly
PMV Pharmaceuticals reports Q3 EPS (34c), consensus (45c)
5M ago
PMVP
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
PremiumPress Releases
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
5M ago
PMVP
PMV Pharmaceuticals price target lowered to $5 from $29 at H.C. Wainwright
PremiumThe Fly
PMV Pharmaceuticals price target lowered to $5 from $29 at H.C. Wainwright
6M ago
PMVP
PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation
PremiumPress Releases
PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation
6M ago
PMVP
PMV Pharmaceuticals’ PC14586 Phase 1 data demonstrates anti-tumor activity
PremiumThe FlyPMV Pharmaceuticals’ PC14586 Phase 1 data demonstrates anti-tumor activity
6M ago
PMVP
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar
PremiumPress Releases
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar
6M ago
PMVP
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
PremiumPress Releases
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
7M ago
PMVP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >